UnitedHealth Group Inc.
Provides health insurance plans, pharmacy services, care management software, and health information systems to employers, government programmes, hospitals, and individual consumers across the United States and internationally.
As of Oct 15, 2026
Summary
UnitedHealth Group operates as a diversified healthcare company spanning insurance, pharmacy benefits, and care services. The stock is trading at $395.62 with a bullish technical lean and has gained 5.2% over the past month and 13.2% over the past year, reflecting sustained upward momentum. The company carries a market capitalisation of $340 billion.
Price history
As of Oct 14, 2026
Performance
+2.79%
+5.22%
+5.24%
-5.98%
+22.21%
+13.24%
As of Oct 14, 2026
Technical indicators
- 62.5
- 2.61Bullish
- 50: 386.16 · 200: 354.82Bullish
- $395.37 / $399.40
Technical Bias
Bullish lean
UnitedHealth Group's technical indicators lean bullish overall: MACD and moving averages both signal upward momentum, while RSI sits neutral at 62.5, suggesting room for further advance without overbought conditions. This is a derived technical read, not investment advice.
A transparent read of the indicators below — not a prediction or recommendation.
As of Oct 14, 2026
Fundamentals
- $340B
- 24.3
- $15.58
- 3.14%
- +0.4%
- $16.1B
- 0.62
- $252.96 – $458.79
- 2.45%
- Sep 14, 2026
- —
As of Oct 16, 2026
Latest news
As of Oct 16, 2026
MonkeyTrade's Take on UnitedHealth Group Inc.
Short-term outlook
The short-term setup on UnitedHealth leans bullish: price sits above both its 50-day ($386.16) and 200-day ($354.82) averages, MACD is positive, and the stock is up 5.2% over the past month. A push through resistance at $399.40 would reinforce this bias, while a slip under support at $395.37 would stall the momentum. No earnings date is set, so near-term moves should stay technically driven.
Medium-term outlook
UnitedHealth's medium-term picture leans constructive but not resounding: a 24.3 P/E alongside near-flat revenue growth of +0.4% asks the margin side to carry the story, and a 3.1% profit margin plus a 2.5% dividend yield gives some support while the bullish technical lean suggests buyers are already positioning ahead of better numbers. The swing factor is revenue growth—a clear reacceleration from +0.4% would validate the technical optimism; continued stagnation would leave the valuation looking stretched.
Key risks
- Revenue growth of just +0.4% year on year shows the top line has barely moved, which may raise questions about near-term momentum.
- The profit margin sits at a slim +3.1%, leaving little cushion if costs rise or pricing pressures build.
- The stock has swung widely over the past year, from a low of $252.96 to a high of $458.79, with shares now at $395.62, highlighting how volatile sentiment has been.
- Healthcare stocks were reported falling broadly in a recent sector update, suggesting UnitedHealth's share price can be pulled around by industry-wide moves regardless of its own fundamentals.
About UnitedHealth Group Inc.
UnitedHealth Group is a major US healthcare company listed on the NYSE under the ticker UNH. Operating in the healthcare plans industry, it is one of the largest names in the broader healthcare sector, combining insurance coverage with health services on a scale few competitors can match. With a market capitalisation of $340B, it ranks among the sector's heavyweights, giving it significant influence over how healthcare plans and related services are priced and delivered across the country.
Looking at its key figures, UnitedHealth trades on a price-to-earnings ratio of 24.3, a gauge of how the market values its earnings relative to its share price. It also offers a dividend yield of +2.5%, reflecting a portion of profits returned to shareholders. Together, these figures give investors a quick read on how the stock is currently valued and the income it provides alongside any share price movement.
How to trade UnitedHealth Group Inc.
Shares like this are usually traded as CFDs. Compare regulated brokers that offer share CFDs — weigh spreads, fees and platforms before you open an account.
AI-assisted research for informational purposes only — not investment advice. Figures are sourced from third-party market data and may be delayed. Do your own research before trading. Your capital is at risk. How we build these pages.